Shire Human Genetic Therapies, Inc.;Regents of the University of Minnesota
发明人:
申请号：
EP14704040.6
公开号：
EP2948476B1
申请日:
2014.01.28
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The present invention provides, among other things, methods and compositions for treating muscular dystrophy, in particular, Duchenne muscular dystrophy (DMD). In some embodiments, a method according to the present invention includes administering to an individual who is suffering from or susceptible to DMD an effective amount of an anti-Flt-1 antibody, or antigen binding fragment thereof, such that at least one symptom or feature of DMD is reduced in intensity, severity, or frequency, or has delayed onset.
